European College of Neuropsychopharmacology (ECNP) is a scientific and medical organization dedicated to improving mental health by advancing the science and practice of neuropsychopharmacology. The ECNP was founded in 1986 by leading European psychiatrists and has since grown into the largest professional body for this field in Europe, with over 3,000 members from more than 60 countries. The ECNP is committed to promoting excellence in research, clinical practice, and education in neuropsychopharmacology, and to fostering communication between scientists, clinicians, patients, and the public.
The ECNP provides a forum for exchanging ideas and sharing information on all aspects of neuropsychopharmacology. The College organizes an annual Congress – the largest gathering of its kind in Europe – which brings together leading researchers and clinicians from around the world to present their latest findings and share their expertise. In addition to the Congress, the ECNP also organizes smaller symposia throughout the year on specific topics of interest. These events provide an opportunity for dialogue between different stakeholders on current issues in neuropsychopharmacology, such as new treatments for mental disorders or ethical challenges posed by advances in brain science.
The ECNP also publishes two peer-reviewed journals: European Neuropsychopharmacology (ENP), the official journal of the College; and Nature Reviews|Neuroscience (NRN), a monthly review journal that covers all aspects of neuroscience. ENP publishes cutting-edge research on all aspects of neuropsychopharmacology, from basic science to clinical applications. NRN provides concise, authoritative reviews of key topics in neuroscience written by leading experts in the field. Both journals are available online free of charge.
In addition to its scientific activities, the ECNP also works to advance public understanding of mental health issues through its Public Education & Information Committee (PEIC). The PEIC produces materials such as fact sheets on specific disorders or treatments; patient information leaflets; infographics; videos; blog posts; articles for popular media outlets; and social media content. This work is aimed at increasing awareness of mental health issues among European citizens and reducing stigma associated with mental illness.